phase 2 retatrutide AmDiabetesAssn @ADA_DiabetesPro And the summary of the P2 trial for in PPL with #obesity #ADA2023 @AmDiabetesAssn @ADA_Pubs #weightloss retatrutide clinical trials phase 2

Y.NishidaT.OgawaW.et al (2022)

Recalls & Warnings October 11, 2023 Family Sentenced to Over 12 Years in Prison for Selling Dangerous Bleach Miracle Mineral Solution as COVID Cure Four Florida men who distributed the toxic bleach solution Miracle Mineral Solution (MMS) as a cure for COVID-19 and other serious medical conditions have been sentenced to 5 to 12 years in prison for conspiring to defraud the United States

Results from the LEAN trial demonstrated that 39% of patients receiving liraglutide achieved histological resolution of NASH compared with merely 9% in the placebo group

For retatrutide , phase 2 data published in the New England Journal of Medicine (2023) demonstrated substantial mean weight reductions over 48 weeks in adults with obesity among the highest figures reported for any pharmacological agent to date

The pharmacological mechanism

The results of major trials are summarized in Table 1